Home › CRL's bottom line continues to be driven by biotech growth, CEO says
 

Keywords :   


CRL's bottom line continues to be driven by biotech growth, CEO says

2015-03-06 03:45:14| Biotech - Topix.net

For the second straight year Charles River Laboratories has seen more of its revenue derived from biotech companies than Big Pharma, CEO James Foster told investors at two conferences on Tuesday and Wednesday. The growth for CRL, which Foster called " an interesting phenomenon worth noting, " comes as biotech companies have become the drug discovery engines of Big Pharma.

Tags: line bottom says growth

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.10Tropical Storm Milton Graphics
06.10Tropical Storm Milton Forecast Discussion Number 5
06.10Hurricane Kirk Graphics
06.10Tropical Storm Milton Wind Speed Probabilities Number 5
06.10Tropical Storm Milton Public Advisory Number 5
06.10Summary for Tropical Storm Milton (AT4/AL142024)
06.10Hurricane Kirk Forecast Discussion Number 29
06.10Hurricane Kirk Wind Speed Probabilities Number 29
More »